Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . April 14th, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Cancer Gene Therapy - A combination treatment strategy could be key to combating liver cancer
Chronic Hepatitis C - Interferon-alpha is effective and safe for children infected with hepatitis C
Hepatitis B Risk Factors - Viral reactivation is a major risk of immunosuppression after transplantation
Hepatitis C Therapy - Short interfering RNAs may be able to extinguish persistent HCV infection
Liver Transplantation - Hepatitis B core antibody-positive and negative donors share similar risks
Artificial Organs - Ex vivo functioning liver uses artificial pulsate and artificial blood
Chronic Liver Disease - Early detection of hepatitis B virus related flares can prevent liver failure
Disease Prevention - Antenatal hepatitis B screening program effective in Italian women
Hepatitis Coinfection - The synergy of hepatitis B and delta virus antigens activates cell signals
Liver Cancer - Gene hypermethylation occurs early in hepatitis B virus-related carcinogenesis
Liver Failure - Jo2 antibody mediates factors that lead to fulminant hepatitis
Nosocomial Infection - Patients with hematological cancers are at high risk for hepatitis C virus
Psychology - Major depression remains a risk for chronic hepatitis C patients on interferon
Toxicology - A common biomarker for oxidative stress can be affected by several factors
Virology - Hepatitis B core protein represses the p53 tumor suppressor gene in liver cells
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
